Rationale for aggressive lipid lowering in high-risk patients.

Cohen, Jerome D

Cohen, Jerome D.

Affiliation

Cohen JD; Saint Louis University School of Medicine, 8138 Westmoreland Ave, St Louis, MO 63105-3731, USA. cohenjd@slu.edu

J Am Osteopath Assoc ; 111(4 Suppl 3): eS7-12, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21593473

Subject(s)

Anticholesteremic Agents/therapeutic use; Cholesterol, LDL/drug effects; Coronary Artery Disease/drug therapy; Hyperlipidemias/drug therapy; Cholesterol, LDL/blood; Coronary Artery Disease/blood; Coronary Artery Disease/prevention & control; Goals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hyperlipidemias/prevention & control; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Reduction Behavior; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Hyperlipidemias / Cholesterol, LDL / Anticholesteremic Agents Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Am Osteopath Assoc Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links